Cargando…

Adjuvant chemotherapy-associated lipid changes in breast cancer patients: A real-word retrospective analysis

Adjuvant chemotherapy may cause alterations in serum lipids in postoperative breast cancer (BC) patients, but the specific alterations caused by different chemotherapy regimens remain unclear. The aim of this study was to investigate the status of serum lipids pre- and post-chemotherapy and to compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Tao, Wang, Chengshi, Tan, Qiuwen, Wang, Zhu, Li, Jiayuan, Chen, Tao, Cui, Kaijun, Wu, Yunhao, Sun, Jiani, Zheng, Danxi, Lv, Qing, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437760/ https://www.ncbi.nlm.nih.gov/pubmed/32871996 http://dx.doi.org/10.1097/MD.0000000000021498

Ejemplares similares

Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients
por: Zhang, Xinyue, et al.
Publicado: (2022)

Chemotherapy-induced prospective memory impairment in breast cancer patients with different hormone receptor expression
por: Li, Wen, et al.
Publicado: (2017)

Acute arterial thrombosis during adjuvant Adriamycin-cyclophosphamide chemotherapy in a patient with early breast cancer: A case report
por: Jang, Lee Chan, et al.
Publicado: (2019)

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017)

Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis
por: Jiang, Mengjie, et al.
Publicado: (2021)

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Comparative efficacy and safety of metronomic chemotherapy in breast cancer: A protocol for network meta-analysis protocol
por: Xie, Ying, et al.
Publicado: (2021)

Antrodia cinnamomea is a potentially effective complementary medicine for adjuvant therapy against breast cancer with bone metastasis: A case report
por: Long, Huei, et al.
Publicado: (2020)

High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
por: Li, Jingping, et al.
Publicado: (2021)

Combination of (125)I brachytherapy and chemotherapy for unresectable recurrent breast cancer: A retrospective control study
por: Tan, Qixing, et al.
Publicado: (2016)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

Changes in ischemia-modified albumin in myocardial toxicity induced by anthracycline and docetaxel chemotherapy
por: Luan, Xiao-Dong, et al.
Publicado: (2017)

The effects of case management for breast cancer patients: A protocol for systematic review and meta-analysis
por: Chai, Yong, et al.
Publicado: (2022)

Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports
por: Yang, Haisong, et al.
Publicado: (2017)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
por: Peng, Jian-Heng, et al.
Publicado: (2019)

Efficacy and safety of Kanglaite injection combined with chemotherapy for women breast cancer: A protocol for systematic review and meta-analysis of randomized clinical trials
por: Cheng, Shengli, et al.
Publicado: (2021)

Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study
por: Yang, Xuan, et al.
Publicado: (2022)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis
por: Yang, Yiming, et al.
Publicado: (2017)

Management of the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: A single-center study
por: Aksoy, Suleyman Ozkan, et al.
Publicado: (2020)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
por: Ma, Hong-Fang, et al.
Publicado: (2023)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer
por: Sun, Tao, et al.
Publicado: (2021)

Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis
por: Lin, Yuxiang, et al.
Publicado: (2020)

The relationship between exposure to particulate matter and breast cancer incidence and mortality: A meta-analysis
por: Zhang, Zhe, et al.
Publicado: (2019)

Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer: Association with clinicopathological characteristics
por: Li, Juncheng, et al.
Publicado: (2021)

Synergistic association of FOXP3(+) tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: A retrospective cohort study
por: Zhao, Xia, et al.
Publicado: (2019)

Efficacy of fulvestrant 500 mg in Chinese postmenopausal women with advanced/recurrent breast cancer and factors associated with prolonged time-to-treatment failure: A retrospective case series
por: Huang, Jian, et al.
Publicado: (2020)

Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer
por: Chen, Yujuan, et al.
Publicado: (2017)

Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study
por: Dai, Zhi-Jun, et al.
Publicado: (2016)

Radiological and clinical findings in sclerosing adenosis of the breast
por: Tan, Hongna, et al.
Publicado: (2019)

Breast liposarcoma with solitary metastasis to the pleura: A case report
por: Lei, Lei, et al.
Publicado: (2017)

Mediastinal desmoplastic small round cell tumor
por: Jin, Dacheng, et al.
Publicado: (2020)

Effectiveness of intervention for aromatase inhibitor-associated musculoskeletal symptoms: A protocol for systematic review and meta-analysis
por: Meng, Hui, et al.
Publicado: (2022)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1f62ghftdo8t7tule0tmd9b926